Back
Zymeworks 10K Form
Sell
20
ZYME
Zymeworks
Last Price:
8.76
Seasonality Move:
20.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-05 | 10Q | ZYME/Zymeworks Quarterly |
| 2020-05-07 | 10Q | ZYME/Zymeworks Quarterly |
| 2020-03-02 | 10K | ZYME/Zymeworks Annual |
| 2019-11-05 | 10Q | ZYME/Zymeworks Quarterly |
| 2019-08-02 | 10Q | ZYME/Zymeworks Quarterly |
| 2019-05-02 | 10Q | ZYME/Zymeworks Quarterly |
Receive ZYME News And Ratings
See the #1 stock for the next 7 days that we like better than ZYME
ZYME Financial Statistics
Sales & Book Value
| Annual Sales: | $412.48M |
|---|---|
| Cash Flow: | $326.48M |
| Price / Cash Flow: | 4.3 |
| Annual Sales: | $7.82 |
| Price / Book: | 1.12 |
Profitability
| EPS (TTM): | 1.77000 |
|---|---|
| Net Income (TTM): | $124.34M |
| Gross Margin: | $11.09M |
| Return on Equity: | 43.58% |
| Return on Assets: | 29.09% |
Zymeworks Earnings Forecast
Key Zymeworks Financial Ratios
- The Gross Profit Margin over the past 4 years for ZYME is 21.43%.
- The Selling, General & Administrative Expenses for ZYME have been equal to 17.79% of Gross Profit Margin.
- The Research & Development expenses have been 50.57% of Revenue.
- The Interest Expense is -0.46% of Operating Income.
- The Net Earning history of ZYME is 30.14% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 3 years.
Zymeworks Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | ZYME |
| CUSIP: | 98985W |
| Website: | zymeworks.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.7 |
| Quick Ratio: | 5.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.55 |
|---|---|
| Forward P/E Ratio: | 0 |